CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
1.020
+0.030 (3.02%)
At close: Jan 30, 2026, 4:00 PM EST
0.9601
-0.0600 (-5.87%)
After-hours: Jan 30, 2026, 4:15 PM EST

CASI Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-39.26-26.94-41.01-36.65-48.29
Depreciation & Amortization
2.333.742.421.821.96
Loss (Gain) From Sale of Assets
-0.48-2.060.07-1.15
Asset Writedown & Restructuring Costs
0.7-8.726.5619.37
Loss (Gain) From Sale of Investments
-1.72.593.57-4.8-4.32
Loss (Gain) on Equity Investments
1.190.050.85--
Stock-Based Compensation
1.317.227.017.777.82
Other Operating Activities
5.921.191.951.622.05
Change in Accounts Receivable
-5.793.42-3.17-5.16-3.35
Change in Inventory
5.83-9.74-4.23-0.553.19
Change in Accounts Payable
-1.721.151.071.49-1.54
Change in Income Taxes
--1.891.98--
Change in Other Net Operating Assets
2.45-0.76-2.31-1.61
Operating Cash Flow
-29.22-19.97-21.09-26.84-25.89
Capital Expenditures
-0.22-0.2-5.61-8.95-1.5
Sale of Property, Plant & Equipment
--0.140.01-
Sale (Purchase) of Intangibles
0.48-2.04--6.56-15.13
Investment in Securities
10.98-8.4330.2--6.32
Other Investing Activities
--6.440.472.31
Investing Cash Flow
11.24-9.6731.16-20.69-20.72
Short-Term Debt Issued
--40.711.25
Total Debt Issued
--40.711.25
Short-Term Debt Repaid
---4-1.55-
Total Debt Repaid
---4-1.55-
Net Debt Issued (Repaid)
----0.841.25
Issuance of Common Stock
17.110.11-32.548.97
Repurchase of Common Stock
--0.28-3.27--0.25
Common Dividends Paid
-0.72-0.74---
Other Financing Activities
-0.96---2.02-2.82
Financing Cash Flow
15.43-0.91-3.2729.6447.15
Foreign Exchange Rate Adjustments
-1.070.521.6-0.472.9
Net Cash Flow
-3.62-30.038.41-18.363.44
Free Cash Flow
-29.45-20.17-26.7-35.79-27.39
Free Cash Flow Margin
-103.19%-59.54%-61.94%-118.63%-180.87%
Free Cash Flow Per Share
-1.92-1.51-1.96-2.63-2.48
Cash Interest Paid
--0.060.04-
Cash Income Tax Paid
-1.81---
Levered Free Cash Flow
-15.22-13.72-17.45-27.29-25.87
Unlevered Free Cash Flow
-14.67-13.71-17.41-27.29-25.86
Change in Working Capital
0.77-7.82-6.65-3.22-3.32
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q